In an emerging field like personalized medicine, there are additional IP areas that you must address. For example, if your company is looking to protect your research and development in personalized medicine and companion diagnostics, you will want to consider the issue of patent eligibility as it relates to nucleic acids, biomarkers, and diagnostic methods currently under review by the U.S. Supreme Court. In addition, ongoing global changes in examination standards for patent applications require you to have a well-planned filing and enforcement strategy in place.
We offer you significant experience in the procurement, management, assessment, and enforcement of your IP in all technologies that impact personalized medicine: genomics, proteomics, pharmacogenomics, pharmacology, bioinformatics, business methods, and medical devices. Our patent and life sciences transactional attorney ranks include more than 40 Ph.D.s in biology and chemistry, with an additional 29 attorneys with Masters degrees in these subjects.
This experience, combined with our technical backgrounds, enables us to understand your technology and innovations from the inside and out, and helps us craft global patent strategies to obtain, assess, and manage your personalized medicine patent portfolios, as well as enforce patents, trademarks, and copyrights that protect your relevant research and development.